Initially prescribed for type-2 diabetes patients to enhance glycemic control, semaglutide has proven efficacy in weight loss through numerous clinical studies
As of December 19, tirzepatide is the only GLP-1 product being removed from the FDAs shortages list, while dulaglutide (Trulicity), semaglutide (Ozempic/Wegovy) and liraglutide (Victoza/Saxenda) remain listed as in shortage. Victoza Goes Generic As of June 2024, Teva launched its generic version of the diabetic GLP-1 medication Victoza, liraglutide
Diabetes mellitus and hypoglycemia
Label Scope & Dosing (NVO): Final oral Wegovy labeldose, titration, warningscould impact reprice of comps and market share assumptions
Back in stock
Healthcare providers prescribing Zepbound should educate patients on safe disposal practices at the time of initiation, and patients should be encouraged to establish a disposal routine that aligns with local regulations and available resources